Research / PLAG / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-21-042508 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
2.56% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.89% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation 67th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.38% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
934.38% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 33th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
74.25% · OPTIONAL · VALID
Gross margin 11th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
5.95% · CORE · VALID
Operating margin 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-22.79% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.46% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 35 states Self-history eligible
Sep 30, 2022 5/7 normalized Level 3 Dec 31, 2021 6/9 normalized Amended as filed Dec 31, 2021 6/9 normalized Amended as filed Dec 31, 2022 5/7 normalized Level 3 Mar 31, 2023 7/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Amended as filed Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2023 8/8 normalized Amended as filed Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 12.58%
Current 2.56%
Delta -10.02% Capex Intensity Decreased
Previous 5.41%
Current 3.89%
Delta -1.52% Cash Generation Increased
Previous -433.16%
Current 17.38%
Delta 450.54% Growth Increased
Previous 167.89%
Current 934.38%
Delta 766.49% Inventory Pressure Decreased
Previous 157.98%
Current 74.25%
Delta -83.73% Margin Decreased
Previous 9.19%
Current 5.95%
Delta -3.24% Profitability Increased
Previous -70.71%
Current -22.79%
Delta 47.91% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.